P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL-WORLD PHYSICIAN’S CHOICE OF THERAPY IN THE LOCOMMOTION STUDY IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Moreau, Philippe, van de Donk, Niels W.C.J., Delforge, Michel, Einsele, Hermann, De Stefano, Valerio, Perrot, Aurore, Besemer, Britta, Pawlyn, Charlotte, Karlin, Lionel, Manier, Salomon, Leleu, Xavier, Thilakarathne, Pushpike, Diels, Joris, Gries, Katharine, Erler-Yates, Nichola, van Nimwegen, Kirsten, Morano, Raúl, Strulev, Vadim, Haddad, Imene, Kobos, Rachel, Smit, Jennifer, Marshall, Alexander, Slavcev, Mary, Mateos, Maria-Victoria, Weisel, Katja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/
http://dx.doi.org/10.1097/01.HS9.0000970820.69075.8f

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/
http://dx.doi.org/10.1097/01.HS9.0000970820.69075.8f

Ejemplares similares